《Table 1Patients’characteristics from the selected studies.》
提示:宽带有限、当前游客访问压缩模式
本系列图表出处文件名:随高清版一同展现
《The clinicopathological and prognostic significance of PD-L1 expression in pancreatic cancer: A meta-analysis》
IHC:immunohistochemistry;NA:not available.
A flow chart of the study selection criteria is shown in Fig.1.The patient characteristics and study quality scores are listed in Table 1.Nine articles with 989 PDAC patients were evaluated.Among these articles,one had no direct data of PD-L1 positive rate[14].Three articles had no available data for prognostic calculation[15–17].Five studies with 688 PDAC patients were included in the prognostic meta-analysis[18–22].One study had the HR and 95%CI for the reported OS directly;Kaplan–Meier curves were used to estimate the HRs and 95%CIs for the remaining studies.
图表编号 | XD0020450400 严禁用于非法目的 |
---|---|
绘制时间 | 2018.04.01 |
作者 | He-Li Gao、Liang Liu、Zi-Hao Qi、Hua-Xiang Xu、Wen-Quan Wang、Chun-Tao Wu、Shi-Rong Zhang、Jin-Zhi Xu、Quan-Xing Ni、Xian-Jun Yu |
绘制单位 | Department of Pancreatic Surgery, Fudan University Shanghai Cancer Center、Department of Oncology, Shanghai Medical College, Fudan University、Shanghai Pancreatic Cancer Institute、Pancreatic Cancer Institute, Fudan University、Department of Pancreatic Surger |
更多格式 | 高清、无水印(增值服务) |